Suppr超能文献

[巴西新冠疫苗的药物警戒:采取的行动、吸取的教训及后续步骤 巴西新冠疫苗的药物警戒:采取的措施、吸取的经验教训及下一步行动]

[Pharmacovigilance of COVID-19 Vaccines in Brazil: Actions Taken, Lessons Learned, and Next StepsFarmacovigilancia de las vacunas contra la COVID-19 en Brasil: medidas adoptadas, enseñanzas extraídas y próximos pasos].

作者信息

Silva Roberta Mendes Abreu, Cabral Cibelle Mendes, Percio Jadher, da Nóbrega Martha Elizabeth Brasil, Kobayashi Carla Dinamerica, Martins Adriano Ferreira, Cardoso Felipe Daniel, Porto Victor Bertollo Gomes, Capovilla Leon, de Moraes Mônica Brauner, Andrade Paulo Henrique Santos, Fernandes Eder Gatti

机构信息

Ministério da Saúde Brasília-DF Brasil Ministério da Saúde, Brasília-DF, Brasil.

Secretaria de Saúde do Distrito Federal Brasília-DF Brasil Secretaria de Saúde do Distrito Federal, Brasília-DF, Brasil.

出版信息

Rev Panam Salud Publica. 2025 Jan 13;49:e1. doi: 10.26633/RPSP.2025.1. eCollection 2025.

Abstract

OBJECTIVE

To document the actions taken by Brazil's National Immunization Program for the pharmacovigilance of COVID-19 vaccines.

METHODS

Documentary research on the period 2020 to 2023. Documentary sources from the national Ministry of Health during COVID-19 vaccination were used to analyze and interpret the actions taken. The analysis was split into two stages: preparation and operationalization. The publications were organized according to title, date of publication, description, and URL.

RESULTS

A total of 86 documents published during the preparation and operationalization of vaccination were found and evaluated. In the preparation phase, a technical advisory board on immunization was set up and specific technical notes were published for COVID-19 vaccines and the introduction of a new information system. In the operationalization stage, the Interinstitutional Committee for Pharmacovigilance of Vaccines and other Immunobiologicals was created. Also, hospital sentinel surveillance systems were established for adverse events of special interest, and surveillance of COVID-19 vaccination safety in pregnant women was implemented.

CONCLUSION

Pharmacovigilance was strengthened in the context of COVID-19 vaccination in Brazil. Given the gaps in knowledge about the new vaccines, as well as the surrounding them, it was necessary to adopt strategies to complement the passive surveillance system for monitoring vaccination safety. Inter-institutional collaboration, the availability of additional resources, and flexible and timely information systems all contributed to a comprehensively effective preparation and response in the pharmacovigilance of COVID-19 vaccines in Brazil.

摘要

目的

记录巴西国家免疫规划针对新冠疫苗开展药物警戒所采取的行动。

方法

对2020年至2023年期间进行文献研究。利用新冠疫苗接种期间国家卫生部的文献来源,分析和解读所采取的行动。分析分为两个阶段:筹备阶段和实施阶段。出版物按照标题、出版日期、描述和网址进行整理。

结果

共找到并评估了在疫苗接种筹备和实施期间发表的86份文件。在筹备阶段,设立了免疫技术咨询委员会,发布了针对新冠疫苗的具体技术说明,并引入了新的信息系统。在实施阶段,成立了疫苗及其他免疫生物制品药物警戒跨机构委员会。此外,还建立了针对特殊关注不良事件的医院哨点监测系统,并对孕妇的新冠疫苗接种安全性进行了监测。

结论

巴西在新冠疫苗接种背景下加强了药物警戒。鉴于对新疫苗及其周围情况的认识存在差距,有必要采取策略来补充监测疫苗接种安全性的被动监测系统。机构间合作、额外资源的可用性以及灵活及时的信息系统都有助于巴西在新冠疫苗药物警戒方面进行全面有效的筹备和应对。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e3b/11726120/455b8fb162a8/rpsp-49-e1_Figure1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验